An analysis using the reverse transcriptase–polymerase chain reaction (RT-PCR) revealed that noncancerous tissue samples contained significantly higher amounts of BID mRNA compared to HCC specimens. The gene discussed is BID; the disease is hepatocellular carcinoma.